173 related articles for article (PubMed ID: 9154658)
41. The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure.
Tsuchida T; Ishimura E; Miki T; Matsumoto N; Naka H; Jono S; Inaba M; Nishizawa Y
Osteoporos Int; 2005 Feb; 16(2):172-9. PubMed ID: 15164161
[TBL] [Abstract][Full Text] [Related]
42. Effects of 12-month GH treatment on bone metabolism and bone mineral density in adults with adult-onset GH deficiency.
Sartorio A; Ortolani S; Galbiati E; Conte G; Vangeli V; Arosio M; Porretti S; Faglia G
J Endocrinol Invest; 2001 Apr; 24(4):224-30. PubMed ID: 11383908
[TBL] [Abstract][Full Text] [Related]
43. One year soy protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal women.
Arjmandi BH; Lucas EA; Khalil DA; Devareddy L; Smith BJ; McDonald J; Arquitt AB; Payton ME; Mason C
Nutr J; 2005 Feb; 4():8. PubMed ID: 15727682
[TBL] [Abstract][Full Text] [Related]
44. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
Uretmen S; Gol M; Cimrin D; Irmak E
Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
[TBL] [Abstract][Full Text] [Related]
45. Biomarkers of bone turnover and bone mineral density in hyperprolactinemic amenorrheic women.
Shaarawy M; El-Dawakhly AS; Mosaad M; El-Sadek MM
Clin Chem Lab Med; 1999 Apr; 37(4):433-8. PubMed ID: 10369115
[TBL] [Abstract][Full Text] [Related]
46. Chinese herbal formula Qilong-Lishui granule improves puromycin aminonucleoside-induced renal injury through regulation of bone morphogenetic proteins.
Li P; Yan J; Sun Y; Burczynski FJ; Gong Y
Nephrology (Carlton); 2007 Oct; 12(5):466-73. PubMed ID: 17803470
[TBL] [Abstract][Full Text] [Related]
47. The acute effects of exercise on bone turnover.
Welsh L; Rutherford OM; James I; Crowley C; Comer M; Wolman R
Int J Sports Med; 1997 May; 18(4):247-51. PubMed ID: 9231839
[TBL] [Abstract][Full Text] [Related]
48. Serum insulin/like growth factor I, bone mineral density and biochemical markers of bone metabolism in children with idiopathic osteoporosis.
Chlebna-Sokol D; Rusinska A
Endocr Regul; 2001 Dec; 35(4):201-8. PubMed ID: 11858767
[TBL] [Abstract][Full Text] [Related]
49. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
[TBL] [Abstract][Full Text] [Related]
50. Low-level lifetime exposure to cadmium decreases skeletal mineralization and enhances bone loss in aged rats.
Brzóska MM; Moniuszko-Jakoniuk J
Bone; 2004 Nov; 35(5):1180-91. PubMed ID: 15542044
[TBL] [Abstract][Full Text] [Related]
51. Effect of dietary antioxidants on puromycin aminonucleoside nephrotic syndrome.
Pedraza-Chaverri J; Arévalo AE; Hernández-Pando R; Larriva-Sahd J
Int J Biochem Cell Biol; 1995 Jul; 27(7):683-91. PubMed ID: 7648424
[TBL] [Abstract][Full Text] [Related]
52. Regional and hormone-dependent effects of apolipoprotein E genotype on changes in bone mineral in perimenopausal women.
Gerdes LU; Vestergaard P; Hermann AP; Mosekilde L
J Bone Miner Res; 2001 Oct; 16(10):1906-16. PubMed ID: 11585357
[TBL] [Abstract][Full Text] [Related]
53. Bone metabolism and bone mineral density in childhood hypophosphatasia.
Girschick HJ; Schneider P; Kruse K; Huppertz HI
Bone; 1999 Sep; 25(3):361-7. PubMed ID: 10495141
[TBL] [Abstract][Full Text] [Related]
54. A prospective study of changes in bone turnover and bone density associated with regaining weight in women with anorexia nervosa.
Bolton JG; Patel S; Lacey JH; White S
Osteoporos Int; 2005 Dec; 16(12):1955-62. PubMed ID: 16027954
[TBL] [Abstract][Full Text] [Related]
55. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
[TBL] [Abstract][Full Text] [Related]
56. Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures.
Mitra D; Elvins DM; Collins AJ
J Rheumatol; 1999 Oct; 26(10):2201-4. PubMed ID: 10529140
[TBL] [Abstract][Full Text] [Related]
57. Pathophysiology of experimental nephrotic syndrome induced by puromicyn aminonucleoside in rats. III. Effect of captopril, an angiotensin converting enzyme inhibitor, on proteinuria and sodium retention.
Pedraza-Chaverrí J; Cruz C; Chávez MT; Ibarra-Rubio ME; Tapia E; Peña JC
Rev Invest Clin; 1990; 42(3):210-6. PubMed ID: 2270368
[TBL] [Abstract][Full Text] [Related]
58. Biochemical markers of bone turnover: an update.
van Daele PL; Birkenhäger JC; Pols HA
Neth J Med; 1994 Feb; 44(2):65-72. PubMed ID: 8208326
[TBL] [Abstract][Full Text] [Related]
59. Cross-sectional evaluation of bone metabolism in men.
Szulc P; Garnero P; Munoz F; Marchand F; Delmas PD
J Bone Miner Res; 2001 Sep; 16(9):1642-50. PubMed ID: 11547833
[TBL] [Abstract][Full Text] [Related]
60. Quantification of biochemical markers of bone turnover by kinetic measures of bone formation and resorption in young healthy females.
Weaver CM; Peacock M; Martin BR; McCabe GP; Zhao J; Smith DL; Wastney ME
J Bone Miner Res; 1997 Oct; 12(10):1714-20. PubMed ID: 9333133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
